Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by Hoosier Cancer Research Network
OncoGenex Technologies
Hoosier Cancer Research Network
Information provided by (Responsible Party):
Noah Hahn, M.D., Hoosier Cancer Research Network Identifier:
First received: January 25, 2013
Last updated: May 14, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)